DAWN - Financial Reports List - Day One Biopharmaceuticals, Inc. - IntrinsicAlpha

Day One Biopharmaceuticals, Inc. DAWN

Healthcare - Biotechnology - NASDAQ - US

$ 7.275

4.39 %

$ 737 M

Market Cap

-7.0

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	5115.71%	-20.55%	-9.77%
Annual Report	FY	10-K	2024-12-31	0.00%	49.45%	-5.44%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	180.25%	157.61%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	90.39%	-133.09%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-76.42%	-45.60%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-56.57%	-39.24%
Annual Report	FY	10-K	2023-12-31	0.00%	-42.93%	-40.27%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-35.75%	-29.57%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-25.55%	-34.14%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-27.51%	-65.26%

1